[1] Turner ML, Schnorfeil FM, Brocker T.MicroRNAs regulate dendritic cell differentiation and function[J].J Immunol, 2011, 187 (8):3911-3917.[2] Leone E, Morelli E, Tassone P, et al.Targeting microRNA-21 inhibits in vitro and in vivo multiple myeloma cell growth[J].Clin Cancer Res, 2013, 19(8):2096-2106.[3] Pichiorri F, Suh SS, Rocci A, et al.Downregulation of p53-inducible microRNAs 192, 194and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development[J].Cancer Cell, 2010, 18(4):367-381.[4] Zhang W, Wang YE, Zhang Y, et al.Global epigenetic regulation of microRNAs in multiple myeloma[J].PLoS One, 2014, 9(10):e110973.[5] Pons A, Nomdedeu B, Navarro A, et al.Hematopoiesis-related microRNA expression in myelodysplastic syndromes[J].Leuk Lymphoma, 2009, 50(11):1854-1859.[6] Chen CZ, Li L, Lodish HF, et al.MicroRNAs modulate hematopoietic lineage differentiation[J].Science, 2004, 303(5653):83-86.[7] Yyusnita Y, Norsiah MD, Zakiah I, et al.MicroRNA (miRNA) expression profiling of peripheral blood samples in multiple myeloma patients using microarray[J].Malays J Pathol, 2012, 34(2):133-143.[8] Lionetti M, Agnelli L, Mosca L, et al.Integrative high-resolution microarray analysis of human myeloma cell lines reveals deregulated microRNA expression associated with allelic imbalances and gene expression profiles[J].Genes Chromosomes Cancer, 2009, 48(6):521-531.[9] Yoshizawa S, Ohyashiki JH, Ohyashiki M, et al.Downregulated plasma miR-92a levels have clinical impact on multiple myeloma and related disorders[J].Blood Cancer J, 2012, 2(1):e53.[10] Xiao C, Srinivasan L, Calado DP, et al.Lymphoproliferative disease and autoimmunity in mice with increased microRNA17-92 expression in lymphocytes[J].Nature Immunol, 2008, 9(4):405-414.[11] Lee SK, Calin GA.Non-coding RNAs and cancer:new paradigms in oncology[J].Discov Med, 2011, 11(58):245-254.[12] Yang X, Liang L, Zhang XF, et al.MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway[J].Hepatology, 2013, 58(1):158-170.[13] Ahmad A, Maitah MY, Ginnebaugh KR, et al.Inhibition of Hedgehog signaling sensitizes NSCLC cells to standard therapies through modulation of EMT-regulating microRNAs[J].J Hematol Oncol, 2013, 6(1):77-86.[14] Nishida N, Nagahara M, Sato T, et al.Microarray analysis of colorectal cancer stromal tissue reveals upregulation of two oncogenic microRNA clusters[J].Clin Cancer Res, 2012, 18(11):3054-3070.[15] Song SD, Zhou J, Zhou J, et al.MicroRNA-375 targets the 3-phosphoinositide-dependent protein kinase-1 gene in pancreatic carcinoma[J].Oncol Lett, 2013, 6(4):953-959.[16] Cui B, Chen L, Zhang S, et al.MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia[J].Blood, 2014, 124(4):546-554.[17] Qu X, Zhao M, Wu S, et al.Circulating microRNA 483-5p as a novel biomarker for diagnosis survival prediction in multiple myeloma[J].Med Oncol, 2014, 31(10):e219.[18] Luo X, Gu J, Zhu R, et al.Integrative analysis of differential miRNA and functional study of microRNA21 by seed-targeting inhibition in multiple myeloma cells in response to berberine[J].BMC Syst Biol, 2014, 8(1):82-91. |